Funder: Eli Lilly and Company
Due Dates (Anticipated): October 2026 (Full application deadline, projected)
Funding Amounts: Support may include study drug and/or financial support; award size and duration vary by proposal.
Summary: Supports investigator-initiated clinical research using Lilly products or funding, based on competitive proposals aligned with Lilly’s posted areas of interest.
Key Information: This is a forecasted cycle; deadlines and areas of interest are subject to annual update.